Delivery Order SPE2DB25D3001-SPE2DB25FQURU
- Not listed
- The Defense Logistics Agency awarded a $1,341.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of July 25, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement needs, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials with a ceiling value of $8,760.11 under a firm fixed-price contract. This award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a child delivery order under the contractor's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside...
- The Defense Logistics Agency awarded a $2,446.99 delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of September 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $2,263.89 firm fixed price delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of August 1, 2025. This competitive award includes no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency awarded a $5,960.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of July 24, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,900.50 for Protopam Chloride 1 GM vials, with an ultimate completion date of July 22, 2025. This non-set-aside contract was competitively awarded on a firm fixed-price basis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Protopam Chloride 1 GM vials with a ceiling value of $5,777.60. This firm fixed-price contract, which has an ultimate completion date of August 7, 2025, represents a routine pharmaceutical procurement supporting the federal medical supply chain. The award was made through open competition with no set-aside designation, leveraging AmerisourceBergen's established relationship...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROTOPAM CHLORIDE 1 GM VIALS, with a ceiling value of $4,292.95 and a period of performance through June 18, 2025. The contract is not set aside and was awarded on June 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,870.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Protopam Chloride 1 GM vials, a medical product, with a period of performance through January 6, 2025. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
- This is a federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, with a ceiling value of $1,525.55, is a Delivery Order for the supply of PROTOPAM CHLORIDE 1 GM VIALS to the Department of Defense's Medical Supply Chain. The contract has no set-aside designation and was awarded on a full and open competition basis. AmerisourceBergen, a subsidiary of...
- SPE2DB25D3001Indefinite Delivery Contract
- SPE2DB25D3001-SPE2DB25FQURUDelivery Order
The Defense Logistics Agency awarded a $1,451.96 delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Protopam Chloride 1 GM vials, with completion scheduled for June 10, 2025. This firm fixed-price contract represents a non-set-aside award made through open competition. The contractor will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support arrangement. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supplier that fulfills extensive pharmaceutical and medical supply needs for military and veteran healthcare systems through the Defense Logistics Agency. The company's federal contract portfolio demonstrates consistent capability in delivering a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The SPE2DX indefinite delivery contract enables the company to supply military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for Protopam Chloride, an antidote used in emergency medical situations, reflects the contractor's role in supporting critical pharmaceutical needs within the federal healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/9/25 |